DoW Orthopaedic, Applied Research Award

The Department of Defense, through the Department of the Army and the U.S. Army Medical Research Acquisition Activity (USAMRAA), is forecasting the Orthopaedic Research Program Applied Research Award. This funding opportunity is part of a broader federal effort to advance military medical research and development, specifically focused on improving outcomes for orthopaedic injuries sustained during combat or service-related activities. The program aligns with the Department of Defense’s mission to enhance the health, readiness, and rehabilitation of Service Members, while also benefiting Veterans, their families, and the general public. The primary purpose of this award is to support applied research that translates foundational knowledge into practical solutions. Applied research under this program is defined as work that refines concepts into potential solutions and evaluates their technical feasibility. The scope includes development of knowledge products, pharmacologic agents, behavioral and rehabilitation interventions, diagnostic and therapeutic techniques, clinical guidance, and emerging technologies. The emphasis is on advancing treatment and restoration of function rather than conducting basic or purely clinical research. Funding is intended to support projects that demonstrate strong scientific rationale and feasibility. Preliminary data is explicitly required, indicating that applicants must already have some level of validated research foundation before applying. Clinical research is not permitted under this opportunity, which restricts the use of funds to preclinical or translational applied research activities. There is no cost sharing or matching requirement, allowing applicants to pursue projects without the need to secure additional matching funds. Eligibility for this opportunity is unrestricted, meaning that a wide range of entities may apply, including academic institutions, nonprofit organizations, for-profit companies, and government entities, subject to any additional clarifications provided in the full solicitation. The program expects all proposed research to demonstrate clear military relevance, ensuring that outcomes are applicable to Service Members and related populations. The application process is expected to open around mid-June 2026, with an estimated submission deadline in mid-November 2026. Applicants will likely be required to submit their proposals through established federal systems such as Grants.gov and the eBRAP platform, which supports Department of Defense biomedical research programs. While specific application components are not detailed in the forecast, typical submissions include technical proposals, budget justifications, and documentation of preliminary data. Awards are anticipated to be announced by late September 2027, with projects expected to begin shortly thereafter. The total estimated program funding is 3,800,000 dollars, with approximately four awards expected to be made. The timeline reflects a standard federal grant review and award cycle, including administrative review, scientific evaluation, and final selection. Applicants may contact the eBRAP Help Desk via phone or email for technical assistance related to submission systems.

Ensure strong preliminary data and clearly demonstrate applied research feasibility and military relevance